Jianbing Hou

996 total citations
24 papers, 629 citations indexed

About

Jianbing Hou is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Jianbing Hou has authored 24 papers receiving a total of 629 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Oncology and 5 papers in Cell Biology. Recurrent topics in Jianbing Hou's work include Ubiquitin and proteasome pathways (7 papers), Glioma Diagnosis and Treatment (4 papers) and Neuroblastoma Research and Treatments (4 papers). Jianbing Hou is often cited by papers focused on Ubiquitin and proteasome pathways (7 papers), Glioma Diagnosis and Treatment (4 papers) and Neuroblastoma Research and Treatments (4 papers). Jianbing Hou collaborates with scholars based in China, Canada and United States. Jianbing Hou's co-authors include Hongjuan Cui, Erhu Zhao, Xiaoxue Ke, Yudong Liu, Pan Huang, Kui Zhang, Yan Du, Xiao Hu, Zhen Dong and Saima Kausar and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and The FASEB Journal.

In The Last Decade

Jianbing Hou

21 papers receiving 626 citations

Peers

Jianbing Hou
Sun Mi Hong South Korea
Longyue L. Cao United States
Michelle Cicchini United States
Qin Yu United States
Riccardo Bazzoni Italy
Rachel W. Goehe United States
Yun‐Hye Jin South Korea
Takeyuki Nagashima Japan
Joanna Maria Merchut‐Maya Denmark
Katherine M. Bever United States
Sun Mi Hong South Korea
Jianbing Hou
Citations per year, relative to Jianbing Hou Jianbing Hou (= 1×) peers Sun Mi Hong

Countries citing papers authored by Jianbing Hou

Since Specialization
Citations

This map shows the geographic impact of Jianbing Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianbing Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianbing Hou more than expected).

Fields of papers citing papers by Jianbing Hou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianbing Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianbing Hou. The network helps show where Jianbing Hou may publish in the future.

Co-authorship network of co-authors of Jianbing Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Jianbing Hou. A scholar is included among the top collaborators of Jianbing Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianbing Hou. Jianbing Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hou, Jianbing, et al.. (2025). RNF6 promotes cell proliferation of glioblastoma by targeting ubiquitin-mediated degradation of p27. Biochemical and Biophysical Research Communications. 752. 151460–151460.
2.
3.
Wang, Yutao, Lei Zhang, Xinyi Wang, et al.. (2025). EGFR/ZBED1 reciprocal regulation promotes stemness and tumorigenesis in glioblastoma. Neuro-Oncology. 28(2). 385–398.
4.
Hou, Jianbing, et al.. (2024). CoCl2‐induced glioma hypoxia environment enhances CD47‐SIRPα to promote tumor immune evasion. SHILAP Revista de lepidopterología. 3(3). 1 indexed citations
5.
Hou, Jianbing, et al.. (2023). Sanggenon C inhibits cell proliferation and induces apoptosis by regulating the MIB1/DAPK1 axis in glioblastoma. SHILAP Revista de lepidopterología. 4(4). e281–e281. 12 indexed citations
6.
7.
Peng, Wen, Xue Wang, Xiao Hu, et al.. (2022). ARIH2 regulates the proliferation, DNA damage and chemosensitivity of gastric cancer cells by reducing the stability of p21 via ubiquitination. Cell Death and Disease. 13(6). 564–564. 12 indexed citations
8.
Hou, Jianbing, Pan Huang, Chao Lan, et al.. (2022). ZC3H15 promotes gastric cancer progression by targeting the FBXW7/c-Myc pathway. Cell Death Discovery. 8(1). 32–32. 15 indexed citations
9.
Zhang, Guanghui, Erhu Zhao, Jianbing Hou, et al.. (2022). HECTD3 promotes gastric cancer progression by mediating the polyubiquitination of c-MYC. Cell Death Discovery. 8(1). 185–185. 12 indexed citations
10.
Hu, Xiao, Ruochen Liu, Jianbing Hou, et al.. (2022). SMARCE1 promotes neuroblastoma tumorigenesis through assisting MYCN-mediated transcriptional activation. Oncogene. 41(37). 4295–4306. 10 indexed citations
11.
Hou, Jianbing, et al.. (2022). ZC3H15 promotes glioblastoma progression through regulating EGFR stability. Cell Death and Disease. 13(1). 55–55. 19 indexed citations
12.
Hou, Jianbing, Yudong Liu, Pan Huang, et al.. (2021). RANBP10 promotes glioblastoma progression by regulating the FBXW7/c-Myc pathway. Cell Death and Disease. 12(11). 967–967. 13 indexed citations
13.
Hou, Jianbing, Yan Du, Yudong Liu, Pan Huang, & Hongjuan Cui. (2020). The Roles of Integrin α5β1 in Human Cancer. OncoTargets and Therapy. Volume 13. 13329–13344. 82 indexed citations
14.
Zhao, Erhu, Jianbing Hou, & Hongjuan Cui. (2020). Serine–glycine-one-carbon metabolism: vulnerabilities in MYCN-amplified neuroblastoma. Oncogenesis. 9(2). 14–14. 28 indexed citations
15.
Zhang, Guanghui, Gang Fu, Jianbing Hou, et al.. (2019). TRIP13 promotes the cell proliferation, migration and invasion of glioblastoma through the FBXW7/c-MYC axis. British Journal of Cancer. 121(12). 1069–1078. 56 indexed citations
16.
Zhao, Erhu, Jianbing Hou, Xiaoxue Ke, et al.. (2019). The Roles of Sirtuin Family Proteins in Cancer Progression. Cancers. 11(12). 1949–1949. 87 indexed citations
17.
Zhu, Shunqin, Zhen Dong, Xiaoxue Ke, et al.. (2018). The roles of sirtuins family in cell metabolism during tumor development. Seminars in Cancer Biology. 57. 59–71. 90 indexed citations
18.
Deng, Qing, Jianbing Hou, Li-Ying Feng, et al.. (2018). PHF19 promotes the proliferation, migration, and chemosensitivity of glioblastoma to doxorubicin through modulation of the SIAH1/β–catenin axis. Cell Death and Disease. 9(11). 1049–1049. 39 indexed citations
19.
20.
Zhao, Erhu, Chunling Tang, Xiaolan Jiang, et al.. (2017). Inhibition of cell proliferation and induction of autophagy by KDM2B/FBXL10 knockdown in gastric cancer cells. Cellular Signalling. 36. 222–229. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sun Mi Hong Breakdown of academic impact, for papers by Longyue L. Cao Breakdown of academic impact, for papers by Michelle Cicchini Breakdown of academic impact, for papers by Qin Yu Breakdown of academic impact, for papers by Riccardo Bazzoni Breakdown of academic impact, for papers by Rachel W. Goehe Breakdown of academic impact, for papers by Yun‐Hye Jin Breakdown of academic impact, for papers by Takeyuki Nagashima Breakdown of academic impact, for papers by Joanna Maria Merchut‐Maya Breakdown of academic impact, for papers by Katherine M. Bever
Rankless by CCL
2026